Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Analytical and Bioanalytical Chemistry|June 28, 2024
Cohort-based strategies as an in-house tool to evaluate and improve phenotyping robustness of LC-MS/MS lipidomics platformsBenedikt Zöhrer, Cristina Gómez, Joaquim Jaumot, et al.
International Journal of Molecular Sciences|December 24, 2021
Distal Lung Microenvironment Triggers Release of Mediators Recognized as Potential Systemic Biomarkers for Idiopathic Pulmonary FibrosisDimitrios Kalafatis, Anna Löfdahl, Per Näsman, et al.
Briefings in Bioinformatics|January 11, 2024
Consensus clustering with missing labels (ccml): a consensus clustering tool for multi-omics integrative prediction in cohorts with unequal sample coverageChuan-Xing Li, Hongyan Chen, Nazanin Zounemat-Kermani, et al.
BMC Medical Genomics|June 21, 2012
Network analysis identifies a putative role for the PPAR and type 1 interferon pathways in glucocorticoid actions in asthmaticsDiego Diez, Susumu Goto, John V Fahy, et al.
Analytical Chemistry|August 4, 2012
Building multivariate systems biology modelsGemma M Kirwan, Erik Johansson, Robert Kleemann, et al.
Respiratory Research|December 5, 2018
Soluble epoxide hydrolase derived lipid mediators are elevated in bronchoalveolar lavage fluid from patients with sarcoidosis: a cross-sectional studyMarcus O D Sjödin, Antonio Checa, Mingxing Yang, et al.
Frontiers in Public Health|May 5, 2023
The role of booster vaccination in decreasing COVID-19 age-adjusted case fatality rate: Evidence from 32 countriesCui Zhou, Åsa M Wheelock, Chutian Zhang, et al.
Respiratory Research|September 19, 2020
Smoking-associated increase in mucins 1 and 4 in human airwaysHeta Merikallio, Riitta Kaarteenaho, Sara Lindén, et al.
The Journal of Allergy and Clinical Immunology|November 14, 2012
Gender differences in the bronchoalveolar lavage cell proteome of patients with chronic obstructive pulmonary diseaseMaxie Kohler, AnnSofi Sandberg, Sanela Kjellqvist, et al.
Eclinicalmedicine|May 4, 2026
Long COVID and risk of incident cardiovascular disease: a prospective cohort study using the Multimorbidity Integrated Registry Across Care Levels in Stockholm (MIRACLE-S) cohortPia Lindberg, Samuel Wiqvist, Maria Juszczyk, et al.
Pageof 6